AU5449194A - Combinations of angiotensin-ii receptor antagonists and diuretics - Google Patents
Combinations of angiotensin-ii receptor antagonists and diureticsInfo
- Publication number
- AU5449194A AU5449194A AU54491/94A AU5449194A AU5449194A AU 5449194 A AU5449194 A AU 5449194A AU 54491/94 A AU54491/94 A AU 54491/94A AU 5449194 A AU5449194 A AU 5449194A AU 5449194 A AU5449194 A AU 5449194A
- Authority
- AU
- Australia
- Prior art keywords
- diuretics
- angiotensin
- combinations
- receptor antagonists
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96624192A | 1992-10-26 | 1992-10-26 | |
US966241 | 1992-10-26 | ||
PCT/US1993/010163 WO1994009778A1 (en) | 1992-10-26 | 1993-10-22 | Combinations of angiotensin-ii receptor antagonists and diuretics |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5449194A true AU5449194A (en) | 1994-05-24 |
Family
ID=25511102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54491/94A Withdrawn AU5449194A (en) | 1992-10-26 | 1993-10-22 | Combinations of angiotensin-ii receptor antagonists and diuretics |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5449194A (en) |
WO (1) | WO1994009778A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
HU219598B (en) * | 1992-12-17 | 2001-05-28 | Sankyo Co. Ltd. | Imidazole- and pyridine derivatives of biphenyl compounds, process for producing them and pharmaceutical compositions containing them |
CA2125251C (en) * | 1993-06-07 | 2005-04-26 | Yoshiyuki Inada | A pharmaceutical composition for angiotensin ii-mediated diseases |
US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
EP0831911B1 (en) * | 1995-06-07 | 2002-04-17 | G.D. Searle & Co. | Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure |
TW442301B (en) | 1995-06-07 | 2001-06-23 | Sanofi Synthelabo | Pharmaceutical compositions containing irbesartan |
WO1996040255A2 (en) * | 1995-06-07 | 1996-12-19 | G.D. Searle & Co. | Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldosterone antagonist |
RO118046B1 (en) * | 1995-06-07 | 2003-01-30 | Gd Searle & Co Chicago | Pharmaceutical association |
WO1996040256A1 (en) * | 1995-06-07 | 1996-12-19 | G.D. Searle & Co. | Method to treat cardiofibrosis with a combination of an angiotensin ii antagonist and spironolactone |
FR2735365B1 (en) * | 1995-06-14 | 1997-09-05 | Sanofi Sa | USE OF AN ANGIOTENSIN II ANTAGONIST AND A BENZOFURANE DERIVATIVE FOR THE PREPARATION OF A MEDICAMENT USEFUL IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS |
GB9613470D0 (en) | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
ATE493973T1 (en) | 2004-06-04 | 2011-01-15 | Teva Pharma | PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN |
GB201116993D0 (en) * | 2011-10-03 | 2011-11-16 | Ems Sa | Pharmaceutical compositions of antihypertensives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5164407A (en) * | 1989-07-03 | 1992-11-17 | Merck & Co., Inc. | Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists |
-
1993
- 1993-10-22 AU AU54491/94A patent/AU5449194A/en not_active Withdrawn
- 1993-10-22 WO PCT/US1993/010163 patent/WO1994009778A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1994009778A1 (en) | 1994-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5873594A (en) | Endothelin receptor antagonists | |
AU3665793A (en) | Fibrinogen receptor antagonists | |
AU2759692A (en) | Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin | |
AU3953795A (en) | Bicyclic neuropeptide y receptor antagonists | |
AU4947997A (en) | Phenyl-substituted bicyclic heterocyclyl derivatives and their use | |
AU3998593A (en) | Angiotensin II antagonists | |
AU4679793A (en) | Endothelin receptor antagonists | |
AU8374491A (en) | Angiotensin II receptor antagonists | |
AU3659897A (en) | Chemokine receptor antagonists and methods of use therefor | |
AU3008997A (en) | Antagonists of gonadotropin releasing hormone | |
AU4030695A (en) | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis | |
AU4873193A (en) | Use of substituted benzimidazoles | |
AU7692996A (en) | Receptor antagonists | |
AU3071397A (en) | Antagonists of gonadotropin releasing hormone | |
AU2020497A (en) | Receptor and transporter antagonists | |
AU5593094A (en) | Bicyclic gnrh antagonists | |
PL311272A1 (en) | Antagonists of endotheline receptors | |
AU3276293A (en) | Angiotensin II receptor antagonists | |
AU5449194A (en) | Combinations of angiotensin-ii receptor antagonists and diuretics | |
AU3461293A (en) | Benzodiazepine derivatives, as CCK and gastrin antagonists | |
HUP9802272A3 (en) | Benzimidazole compounds and their use as modulators of the gaba-a receptor complex | |
PL310386A1 (en) | Antagonists of factor i receptors | |
AU3141197A (en) | Antagonists of gonadotropin releasing hormone | |
AU9069191A (en) | Use of angiotensin ii receptor antagonists in the prevention of restinosis | |
AU5455194A (en) | Substituted phthalazinones as nerotensin antagonists |